Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.
Menu

Royalty Pharma Plc Cl A (RPRX)

Royalty Pharma Plc Cl A (RPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Royalty Pharma acquires royalty interest in AstraZeneca’s cliramitug for up to $425 million from Neurimmune GlobeNewswire - Wed Jul 22, 6:05AM CDT

NEW YORK, July 22, 2026 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it has acquired a portion of Neurimmune’s royalty interest in AstraZeneca’s cliramitug for up to...

RPRX : 59.02 (-0.27%)
Royalty Pharma declares third quarter 2026 dividend GlobeNewswire - Fri Jul 17, 3:15PM CDT

NEW YORK, July 17, 2026 (GLOBE NEWSWIRE) -- The board of directors of Royalty Pharma plc (Nasdaq: RPRX) has approved the payment of a dividend for the third quarter of 2026 of $0.235 per Class A ordinary...

RPRX : 59.02 (-0.27%)
Royalty Pharma to announce second quarter 2026 financial results on August 5, 2026 GlobeNewswire - Wed Jul 15, 3:15PM CDT

NEW YORK, July 15, 2026 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it will report its second quarter 2026 financial results on Wednesday, August 5, 2026 before the U.S....

RPRX : 59.02 (-0.27%)
RPRX
Branded Pharmaceuticals Stocks Q1 Recap: Benchmarking Royalty Pharma (NASDAQ:RPRX) StockStory - Sun Jun 14, 10:33PM CDT

Branded Pharmaceuticals Stocks Q1 Recap: Benchmarking Royalty Pharma (NASDAQ:RPRX)

RPRX : 59.02 (-0.27%)
RPRX
Branded Pharmaceuticals Stocks Q1 Recap: Benchmarking Royalty Pharma (NASDAQ:RPRX) StockStory - Sun Jun 14, 10:33PM CDT

Branded Pharmaceuticals Stocks Q1 Recap: Benchmarking Royalty Pharma (NASDAQ:RPRX)

RPRX : 59.02 (-0.27%)
BAX
3 Unpopular Stocks We’re Skeptical Of StockStory - Thu Jun 11, 11:34PM CDT

3 Unpopular Stocks We’re Skeptical Of

RPRX : 59.02 (-0.27%)
BAX : 26.75 (+7.99%)
KFY : 82.11 (-3.05%)
RPRX
Royalty Pharma (RPRX): Buy, Sell, or Hold Post Q1 Earnings? StockStory - Mon Jun 8, 11:05PM CDT

Royalty Pharma (RPRX): Buy, Sell, or Hold Post Q1 Earnings?

RPRX : 59.02 (-0.27%)
Royalty Pharma to present at the Goldman Sachs 47th Annual Global Healthcare Conference GlobeNewswire - Thu Jun 4, 3:15PM CDT

NEW YORK, June 04, 2026 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it will participate in a fireside chat at the Goldman Sachs 47th Annual Global Healthcare Conference...

RPRX : 59.02 (-0.27%)
GDDY
3 Mid-Cap Stocks We Steer Clear Of StockStory - Sun May 17, 11:33PM CDT

3 Mid-Cap Stocks We Steer Clear Of

RPRX : 59.02 (-0.27%)
GDDY : 99.33 (-5.49%)
AMKR : 48.26 (+12.94%)
RPRX
Royalty Pharma’s Q1 Earnings Call: Our Top 5 Analyst Questions StockStory - Wed May 13, 12:33AM CDT

Royalty Pharma’s Q1 Earnings Call: Our Top 5 Analyst Questions

RPRX : 59.02 (-0.27%)

Barchart Exclusives

Here’s Why Verizon Stock Is a Buy for Income Investors in August Barchart - Thu Jul 30, 6:30PM CDT
A safer dividend, stronger free cash flow, and new growth opportunities make Verizon increasingly attractive for income-focused investors. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.